Academic/Pharmaceutical Industry Postdoc in Neurodegeneration and Drug Discovery

Applications are invited for a unique postdoctoral research opportunity in both academia and industry. An individual is sought to join the laboratories of Dr. Richard Nass at Indiana University School of Medicine and Dr. Kalpana Merchant at Eli Lilly and Company. Dr. Nass’s laboratory incorporates a multidisciplinary approach that utilizes the nematode C. elegans to identify and characterize known and novel molecular components involved in Parkinson’s disease (PD). The joint venture will deploy several in vivo whole-animal screens for the identification of molecular pathways and therapeutic leads that may be involved in or inhibit PD-associated neurodegeneration.

We are seeking highly enthusiastic and motivated individuals with a Ph. D in molecular biology, cell biology, genetics, biochemistry, pharmacology, or similar. Experience with C. elegans is strongly preferred but not essential.

Indiana University and Eli Lilly and Co provide an outstanding environment for biomedical research, and are located within 2 miles of each other. The individual will have a primary appointment within the newly established laboratory of Dr. Richard Nass at Indiana University, and a Visiting Scientist within the laboratory of Dr. Kalpana Merchant at Eli Lilly.

Applicants should submit CV, letter of application, future research interests, and contact information for three references by email to: Dr. Richard Nass, Associate Professor of Pharmacology and Toxicology, Indiana University School of Medicine, 635 Barnhill Drive, MS 549, Indianapolis, IN 46202-5120, email: Review of the applications will begin immediately and will continue until the position is filled.